These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26566778)

  • 1. C-terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism.
    Els-Heindl S; Bellmann-Sickert K; Beck-Sickinger AG
    Biopolymers; 2016 Jan; 106(1):101-8. PubMed ID: 26566778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor.
    Els S; Schild E; Petersen PS; Kilian TM; Mokrosinski J; Frimurer TM; Chollet C; Schwartz TW; Holst B; Beck-Sickinger AG
    J Med Chem; 2012 Sep; 55(17):7437-49. PubMed ID: 22920150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.
    Mokrosiński J; Holst B
    Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side Chain Orientation of Tryptophan Analogues Determines Agonism and Inverse Agonism in Short Ghrelin Peptides.
    Nicke L; Müller R; Geyer A; Els-Heindl S
    ChemMedChem; 2019 Nov; 14(21):1849-1855. PubMed ID: 31442005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor.
    Holst B; Frimurer TM; Mokrosinski J; Halkjaer T; Cullberg KB; Underwood CR; Schwartz TW
    Mol Pharmacol; 2009 Jan; 75(1):44-59. PubMed ID: 18923064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of agonism and inverse agonism in ghrelin receptor.
    Qin J; Cai Y; Xu Z; Ming Q; Ji SY; Wu C; Zhang H; Mao C; Shen DD; Hirata K; Ma Y; Yan W; Zhang Y; Shao Z
    Nat Commun; 2022 Jan; 13(1):300. PubMed ID: 35027551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique interaction pattern for a functionally biased ghrelin receptor agonist.
    Sivertsen B; Lang M; Frimurer TM; Holliday ND; Bach A; Els S; Engelstoft MS; Petersen PS; Madsen AN; Schwartz TW; Beck-Sickinger AG; Holst B
    J Biol Chem; 2011 Jun; 286(23):20845-60. PubMed ID: 21402696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging.
    Chollet C; Bergmann R; Pietzsch J; Beck-Sickinger AG
    Bioconjug Chem; 2012 Apr; 23(4):771-84. PubMed ID: 22372770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
    Els S; Beck-Sickinger AG; Chollet C
    Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.
    Holst B; Cygankiewicz A; Jensen TH; Ankersen M; Schwartz TW
    Mol Endocrinol; 2003 Nov; 17(11):2201-10. PubMed ID: 12907757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
    M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
    J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of dual peptides targeting ghrelin and Y2 receptors to regulate food intake and body weight.
    Kilian TM; Klöting N; Bergmann R; Els-Heindl S; Babilon S; Clément-Ziza M; Zhang Y; Beck-Sickinger AG; Chollet C
    J Med Chem; 2015 May; 58(10):4180-93. PubMed ID: 25905598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists.
    McCoull W; Barton P; Brown AJ; Bowker SS; Cameron J; Clarke DS; Davies RD; Dossetter AG; Ertan A; Fenwick M; Green C; Holmes JL; Martin N; Masters D; Moore JE; Newcombe NJ; Newton C; Pointon H; Robb GR; Sheldon C; Stokes S; Morgan D
    J Med Chem; 2014 Jul; 57(14):6128-40. PubMed ID: 24967667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor.
    McClure KF; Jackson M; Cameron KO; Kung DW; Perry DA; Orr ST; Zhang Y; Kohrt J; Tu M; Gao H; Fernando D; Jones R; Erasga N; Wang G; Polivkova J; Jiao W; Swartz R; Ueno H; Bhattacharya SK; Stock IA; Varma S; Bagdasarian V; Perez S; Kelly-Sullivan D; Wang R; Kong J; Cornelius P; Michael L; Lee E; Janssen A; Steyn SJ; Lapham K; Goosen T
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5410-4. PubMed ID: 23953189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High metabolic in vivo stability and bioavailability of a palmitoylated ghrelin receptor ligand assessed by mass spectrometry.
    Kostelnik KB; Els-Heindl S; Klöting N; Baumann S; von Bergen M; Beck-Sickinger AG
    Bioorg Med Chem; 2015 Jul; 23(14):3925-32. PubMed ID: 25541202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin receptor modulators: a patent review (2011 - 2014).
    Costantino L; Barlocco D
    Expert Opin Ther Pat; 2014 Sep; 24(9):1007-19. PubMed ID: 25047815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of high Basal signaling from the ghrelin receptor.
    Petersen PS; Woldbye DP; Madsen AN; Egerod KL; Jin C; Lang M; Rasmussen M; Beck-Sickinger AG; Holst B
    Endocrinology; 2009 Nov; 150(11):4920-30. PubMed ID: 19819980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.